查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650817

全球生物製药生物分离系统市场

Biopharmaceutical Bioseparation Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 360 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生物製药生物分离系统市场规模将达到 326 亿美元

2024 年全球生物製药生物分离系统市场规模估计为 175 亿美元，预计 2030 年将达到 326 亿美元，2024 年至 2030 年的复合年增长率为 10.9%。层析法技术是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 10.2%，达到 158 亿美元。预计分析期间其他技术部门的复合年增长率为 11.5%。

美国市场规模估计为 73 亿美元，中国市场预估年复合成长率为 13.3%

预计 2024 年美国生物製药生物分离系统市场规模将达 73 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 39 亿美元，2024-2030 年分析期间的复合年增长率为 13.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 9.0% 和 9.3%。在欧洲，德国的复合年增长率预计为 9.8%。

全球生物製药生物分离系统市场 - 主要趋势和驱动因素摘要

生物製药生物分离系统是生物製药生产和精製的重要组成部分，包括治疗性蛋白质、单株抗体、疫苗等。这些系统采用多种技术，包括层析法、过滤和离心法，从复杂混合物中分离和精製生物分子。由于生物製药在治疗慢性和罕见疾病方面的有效性，对生物製药的需求日益增加，从而推动了对高效、可靠的生物分离系统的需求。这些系统对于确保生物製药的纯度、效力和安全性至关重要，因为生物製药必须遵守严格的监管要求。生物分离技术的进步使得生物製药製造过程更有效率、扩充性。

由于生物製药行业的扩张和先进生物分离技术的不断采用，生物製药生物分离市场正在经历显着的成长。慢性病的流行、人口老化以及个人化医疗需求的不断增长正在刺激生物製药的生产。此外，基因和细胞疗法等新治疗方法的发展为生物分离技术带来了新的挑战和机会。材料和方法的创新，例如使用一次性系统和连续处理，使生物分离过程更有效率、更具成本效益。这些进步使得生物製药的生产能够更大规模、更高品质地进行。

生物製药生物分离系统市场的成长受到多种因素的推动。首先，由于慢性病的流行和人口老化，对生物製药的需求不断增加，推动了对高效生物分离系统的需求。其次，一次性系统和连续处理等生物分离技术的进步，使得生物製药生产更具扩充性和成本效益。第三，基因和细胞疗法等新治疗方法的发展为生物分离带来了新的挑战和机会，推动了该领域的创新。最后，生物製药的严格监管要求使得必须使用先进的生物分离系统来确保产品品质和安全。总的来说，这些因素促进了生物製药生物分离系统市场的强劲成长。

部分

技术（层析法、其他技术）

受访企业范例（共61家）

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology（Europe）Ltd.（amsbio）
  • Biotage AB
  • AnteoTech
  • BIA Separations doo
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC（Cytiva）

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP-7973

Global Biopharmaceutical Bioseparation Systems Market to Reach US$32.6 Billion by 2030

The global market for Biopharmaceutical Bioseparation Systems estimated at US$17.5 Billion in the year 2024, is expected to reach US$32.6 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 13.3% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Biopharmaceutical Bioseparation Systems Market - Key Trends & Drivers Summarized

Biopharmaceutical bioseparation systems are critical components in the production and purification of biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines. These systems employ various techniques such as chromatography, filtration, and centrifugation to separate and purify biological molecules from complex mixtures. The demand for biopharmaceuticals is increasing due to their effectiveness in treating chronic and rare diseases, driving the need for efficient and reliable bioseparation systems. These systems are essential for ensuring the purity, potency, and safety of biopharmaceutical products, which are subject to stringent regulatory requirements. Advances in bioseparation technologies are enhancing the efficiency and scalability of biopharmaceutical manufacturing processes.

The biopharmaceutical bioseparation market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing adoption of advanced bioseparation techniques. The rise in the prevalence of chronic diseases, the aging population, and the growing demand for personalized medicine are fueling the production of biopharmaceuticals. Additionally, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation technologies. Innovations in materials and methods, such as the use of single-use systems and continuous processing, are improving the efficiency and cost-effectiveness of bioseparation processes. These advancements are enabling the production of high-quality biopharmaceuticals at larger scales.

The growth in the biopharmaceutical bioseparation systems market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals, driven by the prevalence of chronic diseases and the aging population, is boosting the need for efficient bioseparation systems. Secondly, advancements in bioseparation technologies, including single-use systems and continuous processing, are enhancing the scalability and cost-effectiveness of biopharmaceutical manufacturing. Thirdly, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation, driving innovation in this field. Lastly, stringent regulatory requirements for biopharmaceutical products are necessitating the use of advanced bioseparation systems to ensure product quality and safety. These factors collectively contribute to the robust growth of the biopharmaceutical bioseparation systems market.

SCOPE OF STUDY:

The report analyzes the Biopharmaceutical Bioseparation Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Chromatography, Other Technologies)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • Biotage AB
  • AnteoTech
  • BIA Separations d.o.o.
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC (Cytiva)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 on Biopharmaceutical Bioseparation Market
    • Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Biopharmaceutical Bioseparation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude to Biopharmaceutical Bioseparation Systems
    • A Peek into Biopharmaceutical Manufacturing
    • Downstream Processing of Biosynthetic Products - An Overview
    • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
    • US Remains Market Leader; Developing Countries to Drive Market Growth
    • Chromatography Leads the Pack
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
    • Top 10 Biopharmaceutical Companies: 2023
    • Biological License Application (BLA) Approvals - 2023
    • Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
    • Process Intensification Aids in Greater Productivity
    • Evolution of Chromatography Applications for the Biopharmaceutical Sector
    • Chromatography in Cell & Gene Therapies
    • Chromatography Methods Fraught with Issues
    • Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
    • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
    • Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
    • Specific Guidelines for Biosimilars in Various Countries with Year of Publication
    • Biosimilars Regulatory Agencies in Select Regional Markets
    • Biosimilar Approvals in the US (2023)
    • Biosimilar Approvals in Europe (2023)
    • High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
    • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
    • Chromatography - The Gold Standard Separation Technology
    • Global Chromatography Market (2023): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
    • Increasing Demand for Gas Chromatography in Biopharma Separation
    • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
    • A Comparison of Protein and Synthetic Ligands
    • Pre-packed Disposable Columns in Chromatography Gain Attention
    • SMBC - An Old Approach Gaining Significant Attention
    • Major Advantages and Disadvantages of SMBC
    • Twin-Column SMB - An Emerging Alternative to Protein A Columns
    • Growing Focus on Alternatives to Protein A Chromatography
    • Chiral Chromatography Increases in Popularity
    • Chromatography Efficiency and Selectivity
    • Mixed-Mode Chromatography
    • Multimode Chromatography
    • Mixed-Mode and Multimode Media Offer Cost Savings
    • Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
    • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
    • His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
    • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
    • Downstream Production of Biopharmaceuticals: Filtration Challenges
    • Evolving Membrane Functions in Filtration for the Production of mAbs
    • Filtration Technology: The Future
    • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
    • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
    • Membrane & Bioseparation
    • Need for Highly Efficient Membranes Rises
    • Downstream Response of Industry to Upstream Scale-Up
    • Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
    • Cell Disruption & Methods Gain Popularity
    • Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
    • Affinity Technologies Improve Productivity
    • Nanofiber Chromatography Technology Advantageous
    • Convective Media Set to Gain Growing Use
    • Nanotechnology Set to Add Interesting Dimension to Biological Separation
    • Rise of Magnetic Nanoparticles
    • Magnetic Biological Separation: Key Steps
    • Why Carbon Nanotubes are Gaining Attention
    • Application of Nanoporous & Nanofiber Membranes
    • Key Challenges & the Road Ahead
    • Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
    • Perfusion Gains Attention
    • Use of Continuous Purification on the Rise in Viral Processes
    • Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
    • Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
    • Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
    • Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
    • Continuous Bioseparation Gains Momentum
    • Single-Use Systems Play a Key Role
    • Minimizing Centrifugation Steps
    • Single-Use Disposable Technologies Gain Attention
    • Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
    • Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Growing Preference for Personalized Medicine to Drive Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopharmaceutical Bioseparation Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Facts & Figures
    • Market Analytics
    • TABLE 11: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • TABLE 20: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 29: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 38: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • TABLE 59: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 89: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Africa 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION